Newsletter Subject

How AI could help develop drugs

From

wbur.org

Email Address

newsletters@wbur.org

Sent On

Tue, Mar 19, 2024 07:02 PM

Email Preheader Text

Also: Abortions hit highest number in over a decade, despite some state bans March 19, 2024 Hi

Also: Abortions hit highest number in over a decade, despite some state bans [Donate ❤️]( [View in Browser](  March 19, 2024 Hi CommonHealth reader, Creating new treatments for diseases is an [expensive, time-intensive process]( that typically involves lots of failure. Often, it takes over a decade to make one new drug. And most treatments that initially appear promising in the lab never make it to pharmacy shelves. Could artificial intelligence change that? Many biotech and pharmaceutical companies are [already diving in](. They — and their investors — are betting the newest generation of AI can help unleash novel treatments for everything from COVID-19 to cancer and chronic diseases. While computers — even super smart ones — aren’t developing the drugs themselves, they are helping researchers[reimagine the drug discovery process]( and identify strategies that may be more likely to succeed. Some say AI could make the entire process faster and cheaper. That’s the hope, anyway. I recently spoke with the leaders of several Boston-area biotech companies that are tapping AI to help develop new drugs. Somerville-based Generate:Biomedicines is using AI to generate amino acid sequences for proteins that don’t exist in nature. The proteins are then made and tested in the company's labs. The idea is to expand exponentially the universe of proteins with disease-fighting potential. The company recently started clinical trials for an asthma treatment and a COVID monoclonal antibody treatment using some of the proteins generated with help from AI. Generate:Biomedicines' CEO Mike Nally says the trial is fully enrolled, and all 50 people have received the COVID antibody infusions without major safety concerns. The treatment was developed with astonishing speed. “Our COVID program was 17 months from concept to clinic,” said Nally. The average for comparable treatments is more like [five to six years](. He believes this is just the start for AI. “It’s going to be faster in the future,” Nally said. “These sort of technologies, I think, will allow us to provide a better line of defense against nature's greatest threats.” AI programs excel at handling enormous amounts of data, and looking for patterns and connections within it. Montai, a Cambridge-based drug company, has trained its AI to comb through the chemistry of foods and other commonly ingested substances that are already known to benefit human health. CEO Margo Georgiadis says the AI has helped identify more than 125,000 molecules with strong potential to be starting points to develop safe treatments for chronic diseases, like inflammation. “Think about it as creating a massive human chemist in the cloud that is able to look at any piece of chemistry, no matter how diverse it is,” she explained. Of course, AI systems are only as good as the information humans put into them, and there are plenty of gaps in our knowledge. You can read more about how companies are attempting to [harness the power of AI to create new drugs here](. Elisabeth Harrison Managing Editor For News Content Support the news  This Week's Must Reads [Despite bans in some states, more than a million abortions were provided in 2023]( That's the highest number in more than a decade, according to new research. Medication abortion made up a larger share of the total than in 2020. [Read more.]( [Despite bans in some states, more than a million abortions were provided in 2023]( That's the highest number in more than a decade, according to new research. Medication abortion made up a larger share of the total than in 2020. [Read more.]( [In a pandemic milestone, the NIH ends guidance on COVID treatment]( The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic. [Read more.]( [In a pandemic milestone, the NIH ends guidance on COVID treatment]( The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic. [Read more.]( [From anxiety to cancer, the evidence against ultra-processed food piles up]( Americans consume more than half their daily calories from ultra-processed food. A new study finds consuming lots of this food is linked to a higher risk of many diseases. [Read more.]( [From anxiety to cancer, the evidence against ultra-processed food piles up]( Americans consume more than half their daily calories from ultra-processed food. A new study finds consuming lots of this food is linked to a higher risk of many diseases. [Read more.]( [Mass General, Brigham and Women's hospitals promise closer collaboration]( Two of Boston’s biggest and most prominent academic medical centers plan to work more closely together, combining clinical departments in what they’re describing as an effort to improve care and draw patients from across the country. [Read more.]( [Mass General, Brigham and Women's hospitals promise closer collaboration]( Two of Boston’s biggest and most prominent academic medical centers plan to work more closely together, combining clinical departments in what they’re describing as an effort to improve care and draw patients from across the country. [Read more.]( [A simple blood test can detect colorectal cancer early, study finds]( At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection. [Read more.]( [A simple blood test can detect colorectal cancer early, study finds]( At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection. [Read more.]( What We're Reading 📚 - Famine in northern Gaza is imminent as more than 1 million people face ‘catastrophic’ levels of hunger, new report warns ([CNN]( - When Medicaid Comes After the Family Home ([The New York Times]( - Kids are overscheduled. They’re also lonely. We’ve got to stop pressuring them before it’s too late. ([The Boston Globe]( Your Health [Most inhalers in the U.S. emit climate-warming gasses. Here's what you can do]( When it comes to inhalers commonly used in the U.S., each puff has about the same climate impact as driving a gas-powered car one mile. But increasingly, there are alternative inhalers for some patients. [Read more.]( [Most inhalers in the U.S. emit climate-warming gasses. Here's what you can do]( When it comes to inhalers commonly used in the U.S., each puff has about the same climate impact as driving a gas-powered car one mile. But increasingly, there are alternative inhalers for some patients. [Read more.]( 🧠💥 Did you know...💥🧠 ... some whales go through menopause? Wait, what?! A [recent study in Nature]( suggests menopause may confer an evolutionary advantage by increasing lifespan and allowing female whales to help younger generations — [without the burden]( of caring for their own young. 😎 Forward to a friend. They can sign up [here](. 🔎 Explore [WBUR's Field Guide]( stories, events and more. 📣 Give us your feedback: newsletters@wbur.org 📧 Get more WBUR stories sent to your inbox. [Check out all of our newsletter offerings.]( Support the news     Want to change how you receive these emails? Stop getting this newsletter by [updating your preferences.](  I don't want to hear from WBUR anymore. Unsubscribe from all WBUR editorial newsletters [here.](  Interested in learning more about corporate sponsorship? [Click here.]( Copyright © 2023 WBUR-FM, All rights reserved.

Marketing emails from wbur.org

View More
Sent On

04/12/2024

Sent On

02/12/2024

Sent On

27/11/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

30/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.